Multiple brain lesions in a patient with relapsed hairy cell leukemia: a case report and review of the literature.

Q1 Medicine
CNS Oncology Pub Date : 2025-12-01 Epub Date: 2025-09-26 DOI:10.1080/20450907.2025.2563981
Katell Le Dû, Jacques Delaunay, Maud Voldoire, Thomas Cuvier, Pierre-Yves Renard, Benoît Quilichini, Eric Wafflart, Julien Dubreuil, Sophie Sadot-Lebouvier
{"title":"Multiple brain lesions in a patient with relapsed hairy cell leukemia: a case report and review of the literature.","authors":"Katell Le Dû, Jacques Delaunay, Maud Voldoire, Thomas Cuvier, Pierre-Yves Renard, Benoît Quilichini, Eric Wafflart, Julien Dubreuil, Sophie Sadot-Lebouvier","doi":"10.1080/20450907.2025.2563981","DOIUrl":null,"url":null,"abstract":"<p><p>Cerebral lesions are rare in hairy cell leukemia (HCL), and its incidence remains to be determined. Identifying the cause can be challenging. In this report, we present a case of brain lesions occurring several years after diagnosis. A 76-year-old male patient presented to the Emergency Department with confusion. He had been diagnosed with HCL in 1999 and had received five lines of treatment. Cerebral imaging revealed multiple nodular lesions, with edema and a hemorrhagic appearance. Cerebrospinal fluid tests were negative. The tumor origin was retained due to concomitant relapse (blood, lymph nodes). Despite the partial efficacy of rituximab-cladribine treatment, the patient died of <i>Candida</i> pneumonia. A review of the literature (PubMed, CrossRef, Google Scholar) identified seventeen cases between 1966 and 2024, with a median age of 59 years (33-80). Cladribine, with or without rituximab, was the most widely prescribed treatment regimen with a complete response rate of 57%. Four (23.5%) patients died (two from infection, one from gastrointestinal bleeding and one from an unknown cause). These atypical presentations suggest that brain imaging and advanced biological investigations should be performed to guide management.</p>","PeriodicalId":10469,"journal":{"name":"CNS Oncology","volume":"14 1","pages":"2563981"},"PeriodicalIF":0.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477879/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20450907.2025.2563981","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Cerebral lesions are rare in hairy cell leukemia (HCL), and its incidence remains to be determined. Identifying the cause can be challenging. In this report, we present a case of brain lesions occurring several years after diagnosis. A 76-year-old male patient presented to the Emergency Department with confusion. He had been diagnosed with HCL in 1999 and had received five lines of treatment. Cerebral imaging revealed multiple nodular lesions, with edema and a hemorrhagic appearance. Cerebrospinal fluid tests were negative. The tumor origin was retained due to concomitant relapse (blood, lymph nodes). Despite the partial efficacy of rituximab-cladribine treatment, the patient died of Candida pneumonia. A review of the literature (PubMed, CrossRef, Google Scholar) identified seventeen cases between 1966 and 2024, with a median age of 59 years (33-80). Cladribine, with or without rituximab, was the most widely prescribed treatment regimen with a complete response rate of 57%. Four (23.5%) patients died (two from infection, one from gastrointestinal bleeding and one from an unknown cause). These atypical presentations suggest that brain imaging and advanced biological investigations should be performed to guide management.

复发性毛细胞白血病多发脑损伤1例报告及文献复习。
大脑病变在毛细胞白血病(HCL)中是罕见的,其发病率仍有待确定。确定原因可能具有挑战性。在这个报告中,我们提出了一个病例脑病变发生后几年的诊断。一名76岁男性患者因神志不清到急诊科就诊。他在1999年被诊断出患有HCL,并接受了5次治疗。脑显像显示多发结节性病变,伴有水肿和出血。脑脊液检查呈阴性肿瘤的起源由于合并复发而保留(血液、淋巴结)。尽管利妥昔单抗-克拉德里滨治疗有部分疗效,但患者死于念珠菌肺炎。文献综述(PubMed, CrossRef,谷歌Scholar)确定了1966年至2024年间的17例病例,中位年龄为59岁(33-80岁)。克拉德里滨联合或不联合利妥昔单抗是最广泛使用的治疗方案,完全缓解率为57%。4例(23.5%)患者死亡(2例感染,1例胃肠道出血,1例原因不明)。这些不典型的表现表明,应该进行脑成像和高级生物学检查来指导治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CNS Oncology
CNS Oncology Medicine-Neurology (clinical)
CiteScore
3.80
自引率
0.00%
发文量
12
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信